EnQuest (LSE: ENQ) full-year 2025 results: Production up 5.4%, dividend raised as South East Asia pivot reshapes growth outlook
Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)
Read More 2 minute read Pharma Industry News Bristol Myers Squibb’s subcutaneous nivolumab shows promise in Phase 3 RCC trial Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize… byPallavi MadhirajuJanuary 29, 2024